Nanjing Well Pharmaceutical Co., Ltd. (603351.SH) Latest Company News

Oct 28, 2026, 08:25 UTC
Weier Pharmaceutical reported first-nine-month 2026 revenue of 1.082 billion yuan, up 6.24% year over year, and attributable net profit of 120 million yuan, up 5.24%.
Source:
- finance.sina.cn
Oct 28, 2026, 08:25 UTC
Weier Pharmaceutical reported third-quarter 2026 revenue of 342 million yuan, down 0.69% year over year, and attributable net profit of 43.2591 million yuan, up 4.75%.
Source:
- finance.sina.cn
Oct 14, 2026, 08:27 UTC
Will Pharmaceutical repurchased 53,000 shares for RMB 1.3932 million at RMB 26.13–26.47 per share, representing 0.04% of its total share capital.
Source:
- finance.sina.cn
Oct 12, 2026, 10:16 UTC
Weier Pharmaceutical said it opened a dedicated share-repurchase securities account at China Securities Depository and Clearing Corporation; its previously approved plan is to repurchase shares for employee shareholding or equity incentives using RMB 50 million to RMB 100 million, at no more than RMB 40.11 per share, within 12 months of board approval.
Source:
- finance.sina.cn
Sep 30, 2026, 09:14 UTC
Well Pharmaceutical announced a plan to repurchase its own shares for RMB 50 million to RMB 100 million at a maximum price of RMB 40.11 per share, to be used for an employee stock ownership plan or equity incentive.
Source:
- finance.sina.cn
Aug 19, 2026, 08:52 UTC
Gao Zhengsong, a shareholder holding more than 5% of Weier Pharmaceutical, pledged 3.175 million shares to Guotai Haitong Securities on August 18, 2026, and released the pledge of the same number of shares on August 19, 2026.
Source:
- finance.sina.cn

603351.SH

Weier Pharmaceutical reported first-nine-month 2026 revenue of 1.082 billion yuan, up 6.24% year over year, and attributable net profit of 120 million yuan, up 5.24%.

Weier Pharmaceutical reported third-quarter 2026 revenue of 342 million yuan, down 0.69% year over year, and attributable net profit of 43.2591 million yuan, up 4.75%.

Will Pharmaceutical repurchased 53,000 shares for RMB 1.3932 million at RMB 26.13–26.47 per share, representing 0.04% of its total share capital.

Well Pharmaceutical announced a plan to repurchase its own shares for RMB 50 million to RMB 100 million at a maximum price of RMB 40.11 per share, to be used for an employee stock ownership plan or equity incentive.

Gao Zhengsong, a shareholder holding more than 5% of Weier Pharmaceutical, pledged 3.175 million shares to Guotai Haitong Securities on August 18, 2026, and released the pledge of the same number of shares on August 19, 2026.